Cadent Therapeutics - treatment of ataxia


Cadent Therapeutics (formerly Luc Therapeutics), founded in 2010, is a private biotechnology company based in Cambridge, MA and funded by Atlas Venture Inc., Clal Biotechnology Industries (CBI) and Slater Technology Fund. The company is translating new understandings of human neurobiology into differentiated medicines for serious psychiatric and neurological diseases.

In March 2017, Saniona’s Boston based spinout Ataxion merged with Luc Therapeutics which in October 2017 changed its name to Cadent Therapeutics.

In addition to ownership in the merged Cadent Therapeutics, Saniona is also eligible to receive royalties on any potential products developed and commercialized from the Ataxia-program.